Log in to save to my catalogue

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3463422

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

About this item

Full title

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Health economics review, 2012-03, Vol.2 (1), p.4-4, Article 4

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Invasive (IPD, defined as detection of pneumococci in sterile body fluids like meningitis or bacteremic pneumonia) and non-invasive
Streptococcus pneumoniae
infections (i.e. non-bacteremic pneumonia, otitis media) in adults are associated with substantial morbidity, mortality and costs. In Germany, Pneumococcal polysaccharide va...

Alternative Titles

Full title

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3463422

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3463422

Other Identifiers

ISSN

2191-1991

E-ISSN

2191-1991

DOI

10.1186/2191-1991-2-4

How to access this item